BCAA endurance: 15 studies, no consistent effect on endurance.

BCAA endurance is a combination around which an entire sports nutrition industry has been built. A fresh systematic review shows there's almost no evidence to support it. The Del Guerra team with co-authors analysed 15 studies using PRISMA 2020, Cochrane, and GRADE methodologies. The conclusion is direct: branched-chain amino acids do not provide a significant increase in either performance or recovery for runners and cyclists. Blood biochemistry changes, but the stopwatch doesn't.

What did the BCAA endurance review actually check

The authors searched PubMed, Embase, and Web of Science up to July 2024. Of 152 records found, 15 studies remained after the removal of duplicates and irrelevant papers. The criteria were strict: endurance athletes, branched-chain amino acid or pure leucine supplementation, and measured outcomes for performance, recovery, or fatigue. Reviews and editorials were excluded – only primary data were included.

The total sample size is 519 athletes. Of these, 443 are men, 52 are women, and 24 have an unspecified sex. The authors cite the bias towards male metabolism as a specific limitation. The optimal dosage for women is essentially unstudied, and existing protocols cannot be correctly applied to female physiology.

The research design is mostly randomised controlled trials, plus a few cohort and one cross-sectional study. Doses are widely scattered: from 5g per day to 20g as a single dose. The proportions of valine, leucine and isoleucine also vary from study to study. This heterogeneity makes any combined conclusion difficult in itself.

Why is this question even being asked

The marketing logic sounds convincing. Branched-chain amino acids are oxidised directly in the muscle, unlike most others which are metabolised in the liver. During prolonged exertion, this theoretically provides extra fuel. The second hypothesis is to inhibit «central fatigue» by influencing tryptophan transport and serotonin synthesis in the brain.

The theory is elegant. The problem is that an elegant theory and a measured result are different things. The review precisely addressed the question: does the biochemical effect translate into minutes, metres, and watts of power? Because that's precisely what people pay for when they buy a tub of powder.

The central fatigue hypothesis deserves a separate mention because half of the advertising relies on it. The idea is as follows: during prolonged exertion, more tryptophan enters the brain, from which serotonin is synthesised, and this reduces the motivation to continue. Branched-chain amino acids compete with tryptophan for the same transporter across the blood-brain barrier. Less tryptophan in the brain means less serotonin, leading to later fatigue. Flawless on paper. In actual races, the effect either disappears or gets lost within the margin of error.

What did the performance measurements show

The most telling study compared the decline in muscle power following a run. In the BCAA endurance group, it was −23.01 TP6T, and in the control group, −17.31 TP6T. The difference was not statistically significant (p = 0.13). In other words, the amino acids did not preserve leg power.

The time to exhaustion also didn't shift in most of the jobs. Myoglobin concentration after running was the same between the groups (p = 0.70). Muscle soreness during the run itself – no difference (p = 0.80). These are basic, direct indicators of what interests an athlete. And they are silent.

There were isolated positive signals, but each came with a caveat. One study showed an improvement in 5000m and 10,000m times. However, arginine and citrulline were added to the amino acids, so the pure effect of BCAA endurance could not be isolated. Another found benefits only in slower runners – likely due to lower baseline fitness rather than the supplement itself.

Biochemistry is changing – so what

This is where the main pitfall lies. Biochemical markers responded to BCAA endurance in a clear and predictable manner. Plasma valine levels increased by 140% (p < 0.01). Post-exercise protein synthesis increased by 25% (95% CI: 20–30%, p = 0.01). Plasma glucose decreased, whilst free fatty acids increased as an energy source.

It sounds like direct proof of effectiveness. But all these changes are surrogate indicators. They record that the body did something with the amino acids, not that the athlete ran faster or recovered better. The authors emphasise separately: none of these markers had a proven link to a clinical outcome on the track.

This is a classic case of shifting the goalposts. The blood test «shows something,» the figure looks impressive, and it seems the benefit is proven. [Here you could add a personal example – how easy it is to believe a lab graph moving «in the right direction»]

When do BCAA endurance actually provide any benefit

Let’s be honest about the exceptions, as they shouldn’t be glossed over. One area of the results appeared more consistent than the rest — cognitive performance. Mental performance during the 12 km and 30 km runs improved (p < 0.05) according to the Stroop test. In other words, the mind was working a little more clearly towards the end of the long distance. The mechanism seems plausible, but even here the magnitude of the effect and its practical significance remain open to question.

There was also an indication regarding pain: one trial showed a reduction of 42% (p < 0.05). However, total protein intake was not controlled in that trial. It was the protein in the diet, rather than branched-chain amino acids specifically, that may have produced this effect. A decrease in creatine kinase by 21% and LDH by 6% was also recorded — again as markers, with no link to actual muscle function recovery.

Why can't proof itself be trusted

The most challenging part of the review is the quality assessment. According to the Cochrane RoB 2 and ROBINS-I tools, none of the 15 BCAA endurance studies were classified as having a low risk of bias. All were rated as having a moderate to high risk of bias. Observational studies proved to be the weakest: uncontrolled confounders, biased participant selection, and selective reporting of results.

For GRADE, the certainty of evidence for efficacy was assessed as low. For long-term safety, it was very low indeed. Small sample sizes, a patchwork of protocols, surrogate endpoints instead of functional ones, and a lack of prior registration of studies. On such a basis, evidence-based medicine cannot recommend the supplement.

This pattern will be familiar to anyone who follows nutritional science. Creatine, for example, undergoes the same rigorous scrutiny – and stands up to it, because it is backed by high-quality RCTs. For more on the difference between a supplement that actually works and hype, see our review of creatine for women going through the menopause.

Another weakness lies in the choice of control group. In many studies, BCAA endurance supplements have been compared with water or a calorie-free placebo. However, amino acids themselves provide energy and affect insulin levels. Therefore, part of the «effect» can simply be explained by the fact that one group received calories whilst the other did not. A fair comparison would look different: BCAAs versus an equivalent dose of carbohydrates or complete protein. Then it would become clear whether there is something special about the supplement, or whether it is simply a more expensive way of consuming a few grams of protein.

That's why the authors created a separate reporting guide – BCAA-ERG. This is a list of requirements for future studies: documenting the composition of the supplement, the dosage in g/kg, the time of intake, dietary control, and validated assessment tools. Until this is in place, each new study risks repeating the same mistakes.

The authors' conclusion is unequivocal: branched-chain amino acids are not recommended for endurance athletes. Not because they are harmful, but because there is no evidence of benefit. Furthermore, there are real financial costs and unexplored long-term metabolic risks associated with daily intake.

What actually works instead, and is backed by solid evidence, is: sufficient overall protein intake from food, carbohydrates as long-distance fuel, sleep, and sensible training periodisation. It’s boring, but it works. Incidentally, the fatigue that athletes often attribute to a lack of amino acids frequently has a completely different cause — Mental fatigue set in long before the physical fatigue.

In a nutshell: BCAA Endurance is a case where test-tube biochemistry beat the results on the track. And the marketing beat both of them, selling a tub of powder even before the evidence was in.

---

Sources

• Del Guerra GC, Ohannesian VA, Semerdjian R, et al. Branched-chain amino acid supplementation and endurance performance: reporting guidelines and systematic review of biochemical vs clinical evidence. The Physician and Sportsmedicine. 2026. DOI: 10.1080/00913847.2026.2627863
• Salem A, Ben Maaoui K, Jahrami H, et al. Attenuating Muscle Damage Biomarkers and Muscle Soreness After Exercise-Induced Muscle Damage with BCAA Supplementation: A Systematic Review and Meta-analysis. Sports Med – Open. 2024;10(1):42. DOI: 10.1186/s40798-024-00686-9
• Martinho DV, Nobari H, Faria A, et al. Oral branched-chain amino acids supplementation in athletes: a systematic review. Nutrients. 2022;14(19):4002. DOI: 10.3390/nu14194002